Digital Health Technology Interventions for Improving Medication Safety: Systematic Review of Economic Evaluations

Guardat en:
Dades bibliogràfiques
Publicat a:Journal of Medical Internet Research vol. 27 (2025), p. e65546
Autor principal: Widya, Norma Insani
Altres autors: Neily Zakiyah, Puspitasari, Irma Melyani, Permana, Muhammad Yorga, Parmikanti, Kankan, Rusyaman, Endang, Suwantika, Auliya Abdurrohim
Publicat:
Gunther Eysenbach MD MPH, Associate Professor
Matèries:
Accés en línia:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

MARC

LEADER 00000nab a2200000uu 4500
001 3222368669
003 UK-CbPIL
022 |a 1438-8871 
024 7 |a 10.2196/65546  |2 doi 
035 |a 3222368669 
045 2 |b d20250101  |b d20251231 
100 1 |a Widya, Norma Insani 
245 1 |a Digital Health Technology Interventions for Improving Medication Safety: Systematic Review of Economic Evaluations 
260 |b Gunther Eysenbach MD MPH, Associate Professor  |c 2025 
513 |a Journal Article 
520 3 |a Background:Medication-related harm, including adverse drug events (ADEs) and medication errors, represents a significant iatrogenic burden in clinical care. Digital health technology (DHT) interventions can significantly enhance medication safety outcomes. Although the clinical effectiveness of DHT for medication safety has been relatively well studied, much less is known about the cost-effectiveness of these interventions.Objective:This study aimed to systematically review the economic impact of DHT interventions on medication safety and examine methodological challenges to inform future research directions.Methods:A systematic search was conducted across 3 major electronic databases (ie, PubMed, Scopus, and EBSCOhost). The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed for this systematic review. Two independent investigators conducted a full-text review after screening preliminary titles and abstracts. We adopted recommendations from the Panel on Cost-Effectiveness in Health and Medicine for data extraction. A narrative analysis was conducted to synthesize clinical and economic outcomes. The quality of reporting for the included studies was assessed using the CHEERS (Consolidated Health Economic Evaluation Reporting Standards) guidelines.Results:We included 13 studies that assessed the cost-effectiveness (n=9, 69.2%), cost-benefit (n=3, 23.1%), and cost-utility (n=1, 7.7%) of DHT for medication safety. Of the included studies, more than half (n=7, 53.9%) evaluated a clinical decision support system (CDSS)/computerized provider order entry (CPOE), 4 (30.8%) examined automated medication-dispensing systems, and 2 (15.4%) focused on pharmacist-led outreach programs targeting health care professionals. In 12 (92.3% ) studies, DHT was either cost-effective or cost beneficial compared to standard care. On average, DHT interventions reduced ADEs by 37.12% (range 8.2%-66.5%) and medication errors by 54.38% (range 24%-83%). The key drivers of cost-effectiveness included reductions in outcomes, the proportion of errors resulting in ADEs, and implementation costs. Despite a significant upfront cost, DHT showed a return on investment within 3-4.25 years due to lower cost related with ADE treatment and improved workflow efficiency. In terms of reporting quality, the studies were classified as good (n=10, 76.9%) and moderate (n=3, 23.1%). Key methodological challenges included short follow-up periods, the absence of alert compliance tracking, the lack of ADE and error severity categorization, and omission of indirect costs.Conclusions:DHT interventions are economically viable to improve medication safety, with a substantial reduction in ADEs and medication errors. Future studies should prioritize incorporating alert compliance tracking, ADE and error severity classification, and evaluation of indirect costs, thereby increasing clinical benefits and economic viability. 
651 4 |a United States--US 
653 |a Intervention 
653 |a Databases 
653 |a Economic impact 
653 |a Extraction 
653 |a Smartphones 
653 |a Communication 
653 |a Telemedicine 
653 |a Clinical standards 
653 |a Averages 
653 |a Medical Subject Headings-MeSH 
653 |a Decision support systems 
653 |a Automation 
653 |a Computerized physician order entry 
653 |a Medical technology 
653 |a Medical errors 
653 |a Health services 
653 |a Outreach programs 
653 |a Clinical outcomes 
653 |a Clinical effectiveness 
653 |a Cost analysis 
653 |a Safety 
653 |a Systematic review 
653 |a Drugs 
653 |a Clinical decision making 
653 |a Multimedia 
653 |a Indirect costs 
653 |a Medical screening 
653 |a Compliance 
653 |a Hospitals 
653 |a Critical incidents 
653 |a Medical personnel 
653 |a Cost benefit analysis 
653 |a Tracking 
653 |a Computerization 
653 |a Information technology 
653 |a Computerized decision support systems 
653 |a Text messaging 
653 |a Meta-analysis 
653 |a Errors 
653 |a Classification 
653 |a Methodological problems 
653 |a Costs 
653 |a Support networks 
653 |a Effectiveness 
653 |a Return on investment 
653 |a Medicine 
653 |a Medical decision making 
653 |a Health care expenditures 
700 1 |a Neily Zakiyah 
700 1 |a Puspitasari, Irma Melyani 
700 1 |a Permana, Muhammad Yorga 
700 1 |a Parmikanti, Kankan 
700 1 |a Rusyaman, Endang 
700 1 |a Suwantika, Auliya Abdurrohim 
773 0 |t Journal of Medical Internet Research  |g vol. 27 (2025), p. e65546 
786 0 |d ProQuest  |t Library Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3222368669/abstract/embedded/H09TXR3UUZB2ISDL?source=fedsrch 
856 4 0 |3 Full Text + Graphics  |u https://www.proquest.com/docview/3222368669/fulltextwithgraphics/embedded/H09TXR3UUZB2ISDL?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3222368669/fulltextPDF/embedded/H09TXR3UUZB2ISDL?source=fedsrch